The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures

Non-small cell lung cancer (NSCLC) represents the perfect paradigm of ‘precision medicine’ due to its complex intratumoral heterogeneity. It is truly characterized by a range of molecular alterations that can deeply influence the natural history of this disease. Several molecular alterations have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrara, Miriam Grazia, Stefani, Alessio, Pilotto, Sara, Carbone, Carmine, Vita, Emanuele, Di Salvatore, Mariantonietta, D’Argento, Ettore, Sparagna, Ileana, Monaca, Federico, Valente, Giustina, Vitale, Antonio, Piro, Geny, Belluomini, Lorenzo, Milella, Michele, Tortora, Giampaolo, Bria, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733471/
https://www.ncbi.nlm.nih.gov/pubmed/35004317
http://dx.doi.org/10.3389/fonc.2021.792385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733471/
https://www.ncbi.nlm.nih.gov/pubmed/35004317
http://dx.doi.org/10.3389/fonc.2021.792385

Ejemplares similares